Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
NCT00286208
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
1443
Enrollment
OTHER
Sponsor class
Conditions
Induced Abortion
Interventions
DRUG:
Mifepristone, misoprostol
Sponsor
Gynuity Health Projects